← Leaderboards
Louis I Schure
Curebiotech, Inc.
$125,438
Attributed
$250,876
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$250,876 · 1
By mechanism
R41$250,876 · 1
Top collaborators
- Amit Maity1 shared
Most similar at Curebiotech, Inc.
Same institution · by research overlap
- Yen Tun Wang$1,999,932
- Yen T Wang$202,854
Others in their field
Other Rising Stars on “Advanced Disease”
- Kiran Datta · Leidos Biomedical Research, Inc.$277,585,346
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Mari Ostendorf · University Of Washington$51,931,230
- Gary Mays · Axle Informatics, Llc$30,638,043
- Brian Zavertnik · Palantir Technologies, Inc.$22,886,494
- Kevin Saunders · Duke University$18,106,404
Research focus
Advanced DiseaseAdverse EffectsAftercareAgonistAntigen PresentationAntigen-Presenting CellsAntigensAnti-Pd1 AntibodiesAnti-Pd1 TherapyAntitumor EffectAnti-Tumor Immune ResponseAntitumor ResponseBaseBiological AvailabilityBiotechnologyCancer CellCancer EtiologyCancer PatientCancer TherapyCancer VaccinesCd8b1 GeneCd8-Positive T-LymphocytesChemotherapy And/Or RadiationAbscopal Effect